Hydrogenology
Hydrogenology editorial study record

Hydrogen gas reduces hyperoxic lung injury via the Nrf2 pathway in vivo

Kawamura T, Wakabayashi N, Shigemura N, Huang CS, Masutani K, Tanaka Y, Noda K, Peng X, Takahashi T, Billiar TR, Okumura M, Toyoda Y, Kensler TW, Nakao A. · American Journal of Physiology - Lung Cellular and Molecular Physiology. 2013;304(10):L646-L656.

PreclinicalInhaled H₂Published 2013
Study record, not medical adviceThis page reports one source and Hydrogenology’s source-text extraction. It does not establish that molecular hydrogen is effective, safe or appropriate for any person. Human, animal and laboratory evidence must not be treated as equivalent.
Source and classification

What kind of evidence is this?

Evidence stream

Preclinical

Reported design

Randomized four-gas-condition rat experiment with prolonged-survival cohort and wild-type/Nrf2-knockout mouse mechanistic replication

Research topic

Respiratory health

Administration classification

Inhaled H₂

Study result signal

Not reported in this record.

Outcome type

Not reported in this record.

Reported in the source

Methods at a glance

Population or model

Male Lewis rats and male wild-type or Nrf2-deficient C57BL/6J mice exposed to continuous normoxia or 98% oxygen.

Sample

Outcome-specific groups varied: commonly n=4-8 per condition in rats and n=4 per mouse condition; prolonged rat survival used n=5 per group. The article does not provide one overall animal total.

Duration

Continuous 60-hour exposure for principal outcomes; prolonged hyperoxic survival assessed every eight hours until death.

Intervention

Continuous chamber exposure for 60 hours to 2% H₂ with either 98% O₂ or 98% balanced air; prolonged-survival rats remained exposed beyond 60 hours.

Hydrogen form

Inhaled premixed H₂ with oxygen or balanced air — not Brown's gas: H₂ was 2%, not approximately 66.7%.

H₂ specification

Total chamber flow was 2 L/min. H₂ flow was therefore 40 mL/min. In the hyperoxic mixture, O₂ flow was 1,960 mL/min. The exact O₂ fraction and flow within the separate 98%-balanced-air normoxic mixture are not stated and are not inferred.

H₂ flow

40 mL/min.

O₂ delivered with H₂

1,960 mL/min in the 98% O₂ hyperoxic mixture; not separately reportable for the balanced-air condition.

Comparator

Matching 2% N₂ mixtures under hyperoxia and normoxia, plus Nrf2-wild-type versus Nrf2-deficient mice.

Reported, not endorsed

Outcomes and reported result

Outcomes measured

Blood oxygenation, weight, survival, edema/pleural effusion, lavage cells/protein, histology, cytokines, apoptosis, oxidative damage and Nrf2-dependent genes including HO-1.

Reported result

H₂ improved several rat physiological, edema, inflammatory, apoptotic and survival measures and induced Nrf2-dependent genes. It did not significantly induce HO-1/activity under normoxia. In Nrf2-deficient mice H₂ did not improve oxygenation or gross/histological lung injury and did not induce HO-1/Nqo1/GSTA2, although MDA and 8-OHdG were reduced in both genotypes.

Results-extraction completeness

The complete free PMC article was checked for gas conditions, total flow, directly calculated H₂/O₂ flows, outcome-specific samples, positive and null genotype findings, limitations, funding and available disclosures.

A reported association, difference or mechanism is not automatically a clinical benefit. Null findings, outcome type, study design and precision all matter.

Interpretation limits

Cautions and applicability

Design and reporting cautions

Continuous extreme-hyperoxia animal model, outcome-specific small groups, many surrogate/molecular endpoints and no human participants. The authors could not define how H₂ activates Nrf2. NIH and departmental/fellowship support was reported; no explicit conflict statement was identified, so absence is not inferred.

Applies directly to

Experimental hyperoxic lung injury in rodents; it does not establish prevention or treatment of human oxygen toxicity, ALI or ARDS.

Preliminary appraisal framework

Not reported in this record.

Preliminary risk-of-bias status

Not reported in this record.

Appraisal rationale

Not reported in this record.

No single-study GRADE certainty rating is assigned. Certainty is assessed by important outcome across a complete eligible evidence set, not by attaching a final grade to one source.

Provenance

Sources and record status

Identifiers

PMID: 23475767 · DOI: 10.1152/ajplung.00164.2012

Publisher access

Free full article in PubMed Central.

Extraction basis

Complete PMC article and PubMed metadata; full-text extraction checked 9 August 2026.

Record revision

2026-08-10